• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关于睾酮治疗与心血管风险的结论。

Conclusions about testosterone therapy and cardiovascular risk.

作者信息

Anawalt Bradley D, Yeap Bu B

机构信息

Division of Medicine, University of Washington School of Medicine, Seattle, Washington 98195, United States.

School of Medicine, University of Western Australia, Perth, Western Australia 6009, Australia.

出版信息

Asian J Androl. 2018 Mar-Apr;20(2):152-153. doi: 10.4103/aja.aja_7_18.

DOI:10.4103/aja.aja_7_18
PMID:29457599
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5858099/
Abstract

In this issue of (AJA), several experts have reviewed the latest data on the potential and known effects of endogenous and exogenous testosterone (T) on cardiovascular risk. In the review by Meyer and Wittert, low endogenous serum T appears to be associated with higher risk of cardiovascular disease and overall mortality in certain populations such as Klinefelter syndrome and older men, but not in men with congenital hypogonadotropic hypogonadism. Whether this association is causal or whether low serum testosterone is a marker of other risk factors for cardiovascular disease such as obesity, diabetes mellitus, or other systemic disease is unknown. In Yeap's review of the relationship between circulating endogenous testosterone and its major metabolites, dihydrotestosterone, and estradiol, he raises the provocative hypotheses that there might be differential effects on cardiovascular and cerebrovascular risk related to endogenous testosterone and dihydrotestosterone concentrations. Based on the same epidemiological studies, Yeap postulates that there might be a U-shaped curve for circulating endogenous androgen concentrations such that lower and higher concentrations might confer greater risk of cardiovascular events and all-cause mortality than midrange concentrations. Shores demonstrates in a carefully done review of studies of large prescription databases (including >200 000 men) that testosterone therapy is not associated with overall mortality, myocardial infarction, stroke, or deep venous thrombosis events.

摘要

在本期《美国老年医学会杂志》(AJA)中,几位专家回顾了内源性和外源性睾酮(T)对心血管风险的潜在及已知影响的最新数据。在迈耶和威特特的综述中,低内源性血清睾酮似乎与某些人群(如克兰费尔特综合征患者和老年男性)患心血管疾病及全因死亡的较高风险相关,但在先天性低促性腺激素性性腺功能减退的男性中并非如此。这种关联是否具有因果关系,或者低血清睾酮是否是心血管疾病其他风险因素(如肥胖、糖尿病或其他全身性疾病)的标志物尚不清楚。在叶普对循环内源性睾酮与其主要代谢产物双氢睾酮和雌二醇之间关系的综述中,他提出了一个具有启发性的假设,即内源性睾酮和双氢睾酮浓度可能对心血管和脑血管风险有不同影响。基于相同的流行病学研究,叶普推测循环内源性雄激素浓度可能呈U形曲线,即较低和较高浓度可能比中等浓度带来更大的心血管事件风险和全因死亡率。肖尔斯在对大型处方数据库(包括超过20万名男性)研究的精心综述中表明,睾酮治疗与全因死亡率、心肌梗死、中风或深静脉血栓形成事件无关。

相似文献

1
Conclusions about testosterone therapy and cardiovascular risk.关于睾酮治疗与心血管风险的结论。
Asian J Androl. 2018 Mar-Apr;20(2):152-153. doi: 10.4103/aja.aja_7_18.
2
Management of Hypogonadism in Cardiovascular Patients: What Are the Implications of Testosterone Therapy on Cardiovascular Morbidity?心血管疾病患者性腺功能减退的管理:睾酮治疗对心血管疾病发病率有何影响?
Urol Clin North Am. 2016 May;43(2):247-60. doi: 10.1016/j.ucl.2016.01.011. Epub 2016 Mar 10.
3
The role of testosterone therapy in cardiovascular mortality: culprit or innocent bystander?睾酮治疗在心血管死亡率中的作用:是罪魁祸首还是无辜的旁观者?
Curr Atheroscler Rep. 2015 Mar;17(3):490. doi: 10.1007/s11883-015-0490-0.
4
Testosterone and cardiovascular health.睾酮与心血管健康。
Eur Heart J. 2024 Jan 7;45(2):139-141. doi: 10.1093/eurheartj/ehad513.
5
Cardiovascular Health, Erectile Dysfunction, and Testosterone Replacement: Controversies and Correlations.心血管健康、勃起功能障碍与睾酮替代疗法:争议与关联
Urology. 2017 Dec;110:1-8. doi: 10.1016/j.urology.2017.07.030. Epub 2017 Jul 31.
6
Cardiovascular issues in hypogonadism and testosterone therapy.性腺功能减退与睾酮治疗中的心血管问题。
Am J Cardiol. 2005 Dec 26;96(12B):67M-72M. doi: 10.1016/j.amjcard.2005.10.009. Epub 2005 Dec 19.
7
Testosterone replacement therapy: who to evaluate, what to use, how to follow, and who is at risk?睾酮替代疗法:评估对象、用药选择、随访方式以及风险人群?
Hosp Pract (1995). 2014 Dec;42(5):69-82. doi: 10.3810/hp.2014.12.1160.
8
Hypogonadism: Therapeutic Risks, Benefits, and Outcomes.性腺功能减退:治疗风险、益处及结果
Med Clin North Am. 2018 Mar;102(2):361-372. doi: 10.1016/j.mcna.2017.10.011. Epub 2017 Dec 6.
9
Effect of testosterone replacement on whole body glucose utilisation and other cardiovascular risk factors in males with idiopathic hypogonadotrophic hypogonadism.睾酮替代疗法对特发性低促性腺激素性性腺功能减退男性全身葡萄糖利用及其他心血管危险因素的影响。
Horm Metab Res. 1998 Oct;30(10):642-5. doi: 10.1055/s-2007-978950.
10
Testosterone replacement therapy and cardiovascular events.睾酮替代疗法与心血管事件
Turk Kardiyol Dern Ars. 2017 Oct;45(7):664-672. doi: 10.5543/tkda.2017.00531.

引用本文的文献

1
The complications of male hypogonadism: is it just a matter of low testosterone?男性性腺功能减退症的并发症:仅仅是睾酮水平低的问题吗?
Front Endocrinol (Lausanne). 2023 Jun 28;14:1201313. doi: 10.3389/fendo.2023.1201313. eCollection 2023.
2
The Interplay Between Pituitary Health and Diabetes Mellitus - The Need for 'Hypophyseo-Vigilance'.垂体健康与糖尿病之间的相互作用——对“垂体警觉”的需求
Eur Endocrinol. 2020 Apr;16(1):25-31. doi: 10.17925/EE.2020.16.1.25. Epub 2019 Oct 18.
3
Testosterone deficiency in non-cancer opioid-treated patients.非癌症阿片类药物治疗患者的睾酮缺乏症。
J Endocrinol Invest. 2018 Dec;41(12):1377-1388. doi: 10.1007/s40618-018-0964-3. Epub 2018 Oct 20.

本文引用的文献

1
Randomized controlled trials - mechanistic studies of testosterone and the cardiovascular system.随机对照试验——睾酮与心血管系统的机制研究
Asian J Androl. 2018 Mar-Apr;20(2):120-130. doi: 10.4103/aja.aja_6_18.
2
Testosterone replacement therapy: Dilemmas and challenges in China and Asia.睾酮替代疗法:中国及亚洲地区的困境与挑战
Asian J Androl. 2018 Mar-Apr;20(2):149-151. doi: 10.4103/aja.aja_16_17.
3
Endogenous testosterone and mortality risk.内源性睾酮与死亡风险。
Asian J Androl. 2018 Mar-Apr;20(2):115-119. doi: 10.4103/aja.aja_70_17.
4
Would male hormonal contraceptives affect cardiovascular risk?男性激素避孕药会影响心血管风险吗?
Asian J Androl. 2018 Mar-Apr;20(2):145-148. doi: 10.4103/aja.aja_2_18.
5
Testosterone and its metabolites: differential associations with cardiovascular and cerebrovascular events in men.睾酮及其代谢产物:与男性心血管和脑血管事件的不同关联
Asian J Androl. 2018 Mar-Apr;20(2):109-114. doi: 10.4103/aja.aja_50_17.
6
Testosterone treatment and cardiovascular events in prescription database studies.处方数据库研究中的睾酮治疗与心血管事件
Asian J Androl. 2018 Mar-Apr;20(2):138-144. doi: 10.4103/aja.aja_25_17.
7
Trials of testosterone replacement reporting cardiovascular adverse events.睾酮替代治疗报告心血管不良事件的试验。
Asian J Androl. 2018 Mar-Apr;20(2):131-137. doi: 10.4103/aja.aja_28_17.
8
Testosterone Treatment and Coronary Artery Plaque Volume in Older Men With Low Testosterone.老年男性睾酮水平低时睾酮治疗与冠状动脉斑块体积
JAMA. 2017 Feb 21;317(7):708-716. doi: 10.1001/jama.2016.21043.
9
Effects of Testosterone Treatment in Older Men.睾酮治疗对老年男性的影响。
N Engl J Med. 2016 Feb 18;374(7):611-24. doi: 10.1056/NEJMoa1506119.